Nikki J Moderator Joined Mar 22, 2012 Messages 16,472 Reason PALS Diagnosis 04/2014 Country US State MA City Boston May 10, 2019 #1 Targeting the nuclear pore membrane issue A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis - Full Text View - ClinicalTrials.gov
Targeting the nuclear pore membrane issue A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis - Full Text View - ClinicalTrials.gov
P plcare Member Joined Mar 5, 2019 Messages 22 Reason PALS Diagnosis 03/2019 Country US State FL Jul 22, 2019 #2 I am screening for the Phase 1 trial of BIIB100 tomorrow. Obviously, I'm not expecting any results from a one dose trial, but it feels like a positive step for me.
I am screening for the Phase 1 trial of BIIB100 tomorrow. Obviously, I'm not expecting any results from a one dose trial, but it feels like a positive step for me.
